US-based Biotechnology Company #Moderna Announced That It Has Started Human Trials of an ... - Latest Tweet by IANS Tweets

US-based biotechnology company #Moderna announced that it has started human trials of an #mRNA-based flu shot.

The pharma giant said the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the company's quadrivalent seasonal influenza mRNA vaccine candidate. pic.twitter.com/trer80L9wE— IANS Tweets (@ians_india) July 7, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)